FANCM deficiency is associated with a higher risk of breast cancer and liver cancer, and irreversible lesions are rapidly caused by FANCM deficiency on ALT cells, indicating that short-term inhibition of FANCM can effectively eliminate ALT tumours without secondary effects [64]. This evidence concerns the gene GPT and breast cancer.